Inventor
NORRIS TIMOTHY
US22 patents
⚠️ This page may combine multiple inventors who share the name “NORRIS TIMOTHY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
13 patentsUS6476040B1Nov 5, 2002
Processes and intermediates for preparing anti-cancer compounds
PFIZER106 citations95
US6159976ADec 12, 2000
Polymorph of zopolrestat monohydrate
PFIZER28 citations91
US6262067B1Jul 17, 2001
Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
PFIZER17 citations77
US6066647AMay 23, 2000
Zwitterionic forms of trovafloxacin
PFIZER8 citations65
US5763454AJun 9, 1998
Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
PFIZER11 citations65
US6114531ASep 5, 2000
Process for preparing quinolone and naphthyridone carboxylic acids
PFIZER2 citations62
US5929240AJul 27, 1999
Process and intermediates for preparing naphthyridonecarboxylic acid salts
PFIZER2 citations61
US6239285B1May 29, 2001
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
PFIZER4 citations58
US6753334B2Jun 22, 2004
Preparation of sodium-hydrogen exchanger type-1 inhibitors
PFIZER0 citations51
US6359137B1Mar 19, 2002
Process for preparing trovafloxacin acid salts
PFIZER0 citations51
US6346624B1Feb 12, 2002
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
PFIZER1 citations48
US7019009B2Mar 28, 2006
Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
PFIZER0 citations47
US6080756AJun 27, 2000
Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
PFIZER1 citations45
OSI PHARM INC
4 patentsUS6900221B1May 31, 2005
Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
OSI PHARM INC100 citations94
US7087613B2Aug 8, 2006
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
OSI PHARM INC47 citations89
US6706721B1Mar 16, 2004
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
OSI PHARM INC13 citations79
US7521456B2Apr 21, 2009
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
OSI PHARM INC3 citations57